Molecular Mechanisms, Evidence Levels, and Translational Prospects of Natural Products in Non-Small Cell Lung Cancer: A Critical Narrative Review
Non-small cell lung cancer (NSCLC) accounts for approximately 80–85% of lung cancers and remains a major cause of cancer mortality. Molecular heterogeneity, acquired resistance to targeted therapies, immune escape, and treatment-related toxicity continue to limit durable disease control. Natural products and standardiz...